Helicobacter pylori nanoparticles as a potential treatment of conventional multiple sclerosis. [electronic resource]
- Medical hypotheses 2008
- 1223 p. digital
Publication Type: Letter
0306-9877
10.1016/j.mehy.2007.12.008 doi
Drug Carriers--therapeutic use Helicobacter Infections--complications Helicobacter pylori--immunology Humans Models, Immunological Multiple Sclerosis--therapy Nanoparticles--therapeutic use